Company intelligence / Profile preview

Shuanghu Yuan

Ownership: Private
Development stage: Other

Overview

Shuanghu Capital is a prominent Chinese family office and investment firm established to manage the wealth of Wu Yajun, the founder of Longfor Properties. The firm has a significant focus on the healthcare and life sciences sectors, acting as a key institutional investor in numerous high-growth biotech and pharmaceutical companies. Shuanghu Capital provides venture capital and private equity funding to support innovation in drug discovery, medical devices, and healthcare services. Its portfolio includes major industry players such as Innovent Biologics and WuXi Biologics, reflecting its strategic commitment to the global and domestic healthcare markets.

Industry: Investors

Beyond the preview

Go deeper on Shuanghu Yuan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shuanghu Yuan.

Explore the full profile